Found 0 matching trials
Optimization of Antiviral Therapy of Chronic HBV Infection N/A Along with the improvement of the accuracy of detection of HBV serological ...
Show More Location
Changhai hospital
Learn More & Join Trial
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma PHASE1 To evaluate the safety and toxicity of combination therapy for AIDS-associa...
Show More Location
Mem Sloan - Kettering Cancer Ctr
Learn More & Join Trial
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC N/A This study is being done to analyze the safety, tolerability, and efficacy ...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment PHASE4 This study is to investigate the HBV DNA suppression (and HBeAg seroconvers...
Show More Location
Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital
Learn More & Join Trial
Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B PHASE4 Although the best treatment choice for chronic hepatitis B is not clarified...
Show More Location
National Taiwan University Hospital Department of Internal medicine
Learn More & Join Trial
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma PHASE4 Combination therapy with pegylated interferon-alpha plus ribavirin has grea...
Show More Location
Kaohsiung Medical University Hospital
Learn More & Join Trial
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC PHASE2 RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Show More Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Learn More & Join Trial
A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients PHASE2 The study is designed to assess efficacy of a finitie treatment in Chronic ...
Show More Location
Shanghai Tong Ren Hospital
Learn More & Join Trial
Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects PHASE1 Study design:
This is a randomized, double-blind, placebo- and active-cont...
Show More Learn More & Join Trial
Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study) PHASE3 The purpose of this study was to confirm that combination of narlaprevir (N...
Show More Location
South-Ural State Medical University, Clinic of Medical Academy, Infectious Diseases Department
Learn More & Join Trial